23:20 , Mar 1, 2018 |  BC Innovations  |  Targets & Mechanisms

Checking out the microbiome

What started out as a potential use in stratifying patients is growing into a new avenue for turning non-responders to responders, as evidence continues to emerge linking the microbiome to immuno-oncology. While the data are...
07:00 , Jun 16, 2016 |  BC Innovations  |  Targets & Mechanisms

Vedanta's horizons

Vedanta Biosciences Inc. has followed up its March double-hit of publishing preclinical proof of concept for its homegrown, microbiome-based therapies and in-licensing a new technology to expand the portfolio, with its closing last week of...